Anne Gregor
Has grant
Senior Researcher
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Recent Grants
Grant: Close
Modelling LHX2-associated neurodevelopmental disorder in human brain organoids
Open Date: 2022-01-01
Close Date: 2023-06-01
Grant: Close
The role of protein degradation in FBXO11-related intellectual disability (Degradation_ID)
Open Date: 2019-07-01
Close Date: 2021-07-01
Grant: Close
Characterizing the role of FBXO11 and ubiquitination and proteasomal degradation in intellectual disability
Open Date: 2018-12-01
Close Date: 2019-11-01
Grant: Close
Elucidation of the pathogenesis of Dandy-Walker malformation
Open Date: 2015-01-01
Close Date: 2017-12-31
Articles (14)
Serine/arginine repetitive matrix protein 1 (SRRM1) is a key component of spliceosomes and plays various roles in messenger RNA processing. To date, its function in the nervous system has not been elucidated, and germline variants in SRRM1 have not yet been implicated in disease. Through international collaboration, we have identified three individuals harbouring heterozygous truncating variants in SRRM1 , presenting variably with developmental delay, intellectual disability, short stature, behavioural and skeletal anomalies, and facial dysmorphism. Two of the variants occurred de novo, while the third could not be tested in the parents. Reduction of SRRM1 to 50% in SKNBE2 cells by introducing a truncating variant via CRISPR-Cas9 editing, followed by differentiation into neuron-like cells, resulted in impaired cell proliferation, migration, and neurite outgrowth compared to wild-type cells. Additionally, the role of SRRM1 in nervous system development and functioning was investigated in vivo using a Drosophila model. Pan-neuronal knockdown of the orthologue Srrm1 led to reduced viability, while motoneuronal knockdown impaired gross neurological function. Taken together, we provide multiple lines of evidence that loss of SRRM1 is associated with nervous system-related phenotypes, and that its haploinsufficiency may be causative for a neurodevelopmental disorder.
Year:
2026
Year:
2026
While mostly de novo truncating variants in SCAF4 were recently identified in 18 individuals with variable neurodevelopmental phenotypes, knowledge on the molecular and clinical spectrum is still limited. We assembled data on 50 novel individuals with SCAF4 variants ascertained via GeneMatcher and personal communication. With detailed evaluation of clinical data, in silico predictions and structural modeling, we further characterized the molecular and clinical spectrum of the autosomal dominant SCAF4 -associated neurodevelopmental disorder. The molecular spectrum comprises 25 truncating, eight splice-site and five missense variants. While all other truncating variants were classified as pathogenic/likely pathogenic, significance of one C-terminal truncating variant, one splice-site variant and the missense variants remained unclear. Three missense variants in the CTD-interacting domain of SCAF4 were predicted to destabilize the domain. Twenty-three variants occurred de novo, and variants were inherited in 13 cases. Frequent clinical findings were mild developmental delay with speech impairment, seizures, and skeletal abnormalities such as clubfoot, scoliosis or hip dysplasia. Cognitive abilities ranged from normal IQ to severe intellectual disability (ID), with borderline to mild ID in the majority of individuals. Our study confirms the role of SCAF4 variants in neurodevelopmental disorders and further delineates the associated clinical phenotype.
Year:
2025
While de novo missense variants in the BTB domains of atypical RhoGTPase RHOBTB2 cause a severe developmental and epileptic encephalopathy, de novo missense variants in the GTPase domain or bi-allelic truncating variants are associated with more variable neurodevelopmental and seizure phenotypes. Apart from the observation of RHOBTB2 abundance resulting from BTB-domain variants and increased seizure susceptibility in Drosophila overexpressing RhoBTB, our knowledge on RHOBTB2-related pathomechanisms is limited. We now found enrichment for ion channels among the differentially expressed genes from RNA-Seq on fly heads overexpressing RhoBTB. Subsequent genetic interaction experiments confirmed a functional link between RhoBTB and paralytic, the orthologue of human sodium channels, including epilepsy associated SCN1A, in vivo. We then performed patch-clamp recordings on mature neurons differentiated from human induced pluripotent stem cells with either homozygous frameshifts or patient-specific heterozygous missense variants in the GTPase or the BTB domains. This revealed significantly altered neuronal activity and excitability resulting from BTB domain variants but not from GTPase domain variants or upon complete loss of RHOBTB2. Our study indicates a role of deregulated ion channels in the pathogenesis of RHOBTB2-related developmental and epileptic encephalopathy and points to specific pathomechanisms underlying the observed genotype–phenotype correlations regarding variant zygosity, location and nature.
Year:
2025
Year:
2025
Year:
2025
The dyskerin encoding gene DKC1 plays an important role in telomerase activity and telomere maintenance. Pathogenic variants in DKC1 cause an X‐linked multiorgan disease called dyskeratosis congenita (DC), the most severe form of which is Hoyeraal–Hreidarsson syndrome (HHS). HHS due to DKC1 variants has so far only been reported in hemizygous males and is associated with severe neurological impairment and progressive bone marrow failure, often causing lethality in early childhood. Heterozygous carrier females are often phenotypically normal. Here, we report a young adult female carrying a de novo splice‐site variant in DKC1 and presenting with clinical features overlapping with HHS, such as intrauterine and postnatal growth retardation, microcephaly, intellectual disability, and recurrent infections, while lacking other typical aspects such as dermatological manifestations, cerebellar hypoplasia, or bone marrow failure. Aberrant splicing was confirmed with an in vitro assay, and further analysis revealed very short telomere lengths in the individual, supporting a causative role of the DKC1 variant. Our observations therefore suggest that heterozygous splice‐site variants in DKC1 leading to loss of function might result in a phenotype overlapping with but not being typical for HHS in females, supporting a potential genotype–phenotype correlation.
Year:
2025
Two Jack-Russell Terrier × Chihuahua mixed-breed littermates with Leigh syndrome were investigated. The dogs presented with progressive ataxia, dystonia, and increased lactate levels. Brain MRI showed characteristic bilateral symmetrical T2 hyperintense lesions, histologically representing encephalomalacia. Muscle histopathology revealed accumulation of mitochondria. Whole genome sequencing identified a missense variant in a gene associated with human Leigh syndrome, NDUFS7 :c.535G > A or p.(Val179Met). The genotypes at the variant co-segregated with the phenotype in the investigated litter as expected for a monogenic autosomal recessive mode of inheritance. We investigated the functional consequences of the missense variant in a Drosophila melanogaster model by expressing recombinant wildtype or mutant canine NDUFS7 in a ubiquitous knockdown model of the fly ortholog ND-20. Neither of the investigated overexpression lines completely rescued the lethality upon knockdown of the endogenous ND-20. However, a partial rescue was found upon overexpression of wildtype NDUFS7, where pupal lethality was moved to later developmental stages, which was not seen upon canine mutant overexpression, thus providing additional evidence for the pathogenicity of the identified variant. Our results show the potential of the fruit fly as a model for canine disease allele validation and establish NDUFS7 :p.(Val179Met) as causative variant for the investigated canine Leigh syndrome .
Year:
2024
Year:
2024
In this review we describe different model organisms and systems that are commonly used to study syndromic disorders. Different use cases in modeling diseases, underlying pathomechanisms and specific effects of certain variants are elucidated. We also highlight advantages and limitations of different systems. Models discussed include budding yeast, the nematode worm, the fruit fly, the frog, zebrafish, mice and human cell-based systems.
Year:
2024
Year:
2024
Year:
2023
Year:
2023
Year:
2023
Collaborators (18)
Sangmoon Lee
University of California, San Diego
Gabriele Siegel
University of Zurich
Anna Ruiz
Institute of Research and Innovation Parc Tauli
Christiane Zweier
Head
Inselspital Universitätsspital Bern
Annemieke Aartsma-Rus
Professor of Translational Genetics
Leiden University Medical Center
Mina Ryten
University College London
Julian Martinez-Agosto
Associate Professor (with tenure)
David Geffen School of Medicine at UCLA
Amica Müller-Nedebock
Staff Scientist
University Hospital Leipzig
Timothy Yu
Associate Member
Broad Institute
Alice Davidson
Professor of Molecular Genetics
University College London
Maya Chopra
Director of Translational Genomic Medicine
Boston Children's Hospital
Matthis Synofzik
Professor
Hertie Institute for clinical brain research
Thomas Nevian
University of Bern
Kristen Deak
Assistant Professor
Duke University
Gregory Costain
Hospital for Sick Children
Stephan Sanders
Professor of Paediatric Neurogenetics
University of Oxford
Robert Harvey
Associate Dean, Research, School of Health
University of the Sunshine Coast
Hormos Salimi Dafsari
Max Planck Institute for Biology of Ageing
Make your next move.
Prepare your application
Review drafts before you send them.